SciBase
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Landsvägen 39, Sundbyberg, Stockholm, 17...Phone Number
+46 841062000Website
www.scibase.comRevenue
<$5 MillionStock Symbol
SCIBIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SciBase
SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. Further development has led to Nevisense also being used as a tool to assess the skin barrier and inflammation. SciBase was founded by Stig Ollmar, Associate Professor at The Karolinska Institute in Stockholm, Sweden. Nevisense is based on substantial research and has achieved excellent results in the largest clinical study ever conducted on the detection of malignant melanoma. Nevisense is CE marked in Europe, has TGA approval in Australia and an FDA approval (PMA) in the United States. Nevisense is based on a method called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human tissue to categorize cellular structures and tRead more
SciBase Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SciBase your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
SciBase, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once SciBase has new funding data
Congratulate Masked Content for being promoted to Masked Content at SciBase
Product Launch: Get notified when SciBase launches new products
Website visits: Recent activity has been detected on your website
Click to see if SciBase had a recent Job posting/layoffs
Check if SciBase has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on SciBase recently announced quarterly report
Check out if SciBase is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
SciBase is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SciBase is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SciBase.
SciBase financials insights
Gather financial insights about SciBase, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Debt
$2.1M
SciBase Tech Stack
A closer look at the technologies used by SciBase
See more technologies
Most Recent Scoops
Funding
Funding
Partnership
Partnership, Product Management, Intellectual Property, Legal Affairs, Healthcare Technology
Project
Sales, Pharmaceuticals, Healthcare Operations
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
SciBase News & Media
First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase
STOCKHOLM, June 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced that the first patient has been enrolled in a new study to assess flare prediction in Atopic Dermatitis. The primary objective of...Study that highlights Nevisense potential for prediction of AD published in leading journal
STOCKHOLM, June 9, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced the publication of a study in the peer-reviewed journal Allergy demonstrating that results from Nevisense measurements obtained...Study that highlights Nevisense potential for prediction of AD published in leading journal
STOCKHOLM, June 9, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced the publication of a study in the peer-reviewed journal Allergy demonstrating that results from Nevisense measurements obtained...SciBase announces that the board of directors has resolved on the record date for the reverse share split
STOCKHOLM, May 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that the board of directors has resolved on the record date for the reverse share split. At the Annual General...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SciBase
Sign Up For FreeTo access detailed company insights
SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. Further development ha... Read More
